Spain's INGESA (Instituto Nacional de Gestion Sanitaria) dishes out Euro150 million medtech boost
This article was originally published in Clinica
Spain's national healthcare management institute - Instituto Nacional de Gestion Sanitaria (INGESA) - is already making its mark, after taking over some of the responsibilities of the now defunct Insalud in the newly devolved healthcare system. INGESA was established on August 2 2002, under Royal Decree 840/2002, which defines the restructuring of the Spanish ministry of health and consumer affairs. The institute is responsible for overseeing healthcare under the reformed Servicio Nacional de Salud (SNS) in the devolved regions and for providing the service in the African enclaves of Ceuta and Melilla.
You may also be interested in...
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.